Piracetam

Piracetam (2-Oxo-1-pyrrolidineacetamide) Research Standard

Piracetam (2-oxo-1-pyrrolidineacetamide) is a cyclic derivative of the endogenous neurotransmitter GABA and serves as the foundational parent compound of the racetam class. As the archetype for this series, it has been a cornerstone of neuropharmacological research since 1964. Its defining characteristic in scientific literature is its complex, unresolved mechanism of action, which continues to drive investigations into membrane biophysics, neuronal excitability, and mitochondrial bioenergetics. Because it acts as an all-encompassing scaffold for the entire racetam series, it remains a requisite reference standard for structure-activity relationship (SAR) studies.

Physical & Handling Properties

Mechanism of Action & Research Context

Piracetam’s pharmacology remains a subject of active study. It does not function as a direct agonist or antagonist at any single identified receptor, which distinguishes it from more targeted pharmaceutical agents.

• Membrane Biophysics: Research investigates the compound’s interaction with the phospholipid bilayer, hypothesizing that it modulates neuronal membrane fluidity, which may indirectly influence receptor protein function and cellular signaling efficiency.

• AMPA Receptor Modulation: Studies have explored the allosteric modulation of AMPA-type glutamate receptors, proposing that piracetam may influence receptor density or sensitivity in specific neuronal populations.

• Mitochondrial Bioenergetics: Investigations into mitochondrial function suggest that piracetam may influence oxygen and glucose consumption pathways, providing a stable model for studying cellular energy metabolism under stress.

Research Applications

Piracetam is utilized primarily as a standardized reference compound in comparative neuropharmacology and biophysical studies.

Primary fields of in vitro laboratory investigation include:

• Membrane Biophysics: Mapping the interactions between pyrrolidinone derivatives and phospholipid model systems to understand how chemical structure influences bilayer dynamics.

• AMPA Receptor Signaling: Using piracetam as a comparative tool in glutamate receptor modulation assays.

• Mitochondrial Respirometry: Measuring bioenergetic shifts and ATP production efficiency in cellular cultures exposed to varying concentrations of the parent racetam scaffold.

• Structure–Activity Relationship (SAR) Research: Serving as the definitive control molecule when evaluating the binding affinity or signaling modulation of newer, higher-potency racetam derivatives.

Storage & Handling Guidelines

Store at controlled room temperature. Keep tightly closed.

Storage guidance is a house recommendation. Analytical documentation is per-lot release testing.

References

• Giurgea C. (1973) "The 'nootropic' approach to the pharmacology of the integrative activity of the brain." Cond. Reflex. 8(2): 108–115.

• Malykh AG, Sadaie MR. (2010) "Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders." Drugs. 70(3): 287–312.

Related Research Compounds

• Nefiracetam
• Noopept
• Oxiracetam
• Phenylpiracetam Hydrazide

Research Use Disclaimer

Research Use Only Disclaimer: This product is labeled and sold "For Research Use Only - NOT FOR HUMAN CONSUMPTION." It is not a drug, dietary supplement, food, cosmetic, or medical device, and it is not approved by the FDA or any other regulator for human or veterinary use. It is supplied to approved account holders as a research chemical for laboratory use and must be handled in accordance with applicable law.